Systematic review: Asian patients with chronic hepatitis C infection.
about
Hepatitis C genotype 6: A concise review and response-guided therapy proposalInterferon Lambda 4 Polymorphism Predicts Sustained Viral Response in Hepatitis C Virus Patients Irrespective of Hepatitis C Virus Genotypes, Ethnicity or Treatment Regimen: Results From a Meta-AnalysisHepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implicationOverview and recent trends of systematic reviews and meta-analyses in hepatology.Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa.Determining hepatitis C virus genotype distribution among high-risk groups in Iran using real-time PCR.Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients.Early viral kinetics during hepatitis C virus genotype 6 treatment according to IL28B polymorphismsVariations in DEPDC5 gene and its association with chronic hepatitis C virus infection in Saudi Arabia.Caregiver burden and its determinants among family members of patients with chronic viral hepatitis in Shanghai, China: a community-based survey.Hepatitis B and C co-infection among HIV-infected adults while on antiretroviral treatment: long-term survival, CD4 cell count recovery and antiretroviral toxicity in CambodiaMeta-analysis: superior treatment response in Asian patients with hepatitis C virus genotype 6 versus genotype 1 with pegylated interferon and ribavirinComparison Stratagems of Post-Screening Management of Anti-HCV-Positive Community Residents: Simple Notification, Active Referral, or Accessible Medical Care.24 versus 48 Weeks of Peginterferon Plus Ribavirin in Hepatitis C Virus Genotype 6 Chronically Infected Patients with a Rapid Virological Response: A Non-Inferiority Randomized Controlled TrialPredictors of Pegylated Interferon Alpha and Ribavirin Efficacy and Long-Term Assessment of Relapse in Patients With Chronic Hepatitis C: A One-Center Experience From ChinaHuge gap between clinical efficacy and community effectiveness in the treatment of chronic hepatitis C: a nationwide survey in Taiwan.How hepatitis C patients manage the treatment process of pegylated interferon and ribavirin therapy: a qualitative study.Hepatitis C Virus Infection Associated With an Increased Risk of Deep Vein Thrombosis: A Population-Based Cohort Study.Racial Disparities in Treatment Rates for Chronic Hepatitis C: Analysis of a Population-Based Cohort of 73,665 Patients in the United States.Polymorphisms of HLA-DM on Treatment Response to Interferon/Ribavirin in Patients with Chronic Hepatitis C Virus Type 1 Infection.Screening and management of viral hepatitis and hepatocellular carcinoma in Mongolia: results from a survey of Mongolian physicians from all major provinces of Mongolia.Real-world experience with interferon-free, direct acting antiviral therapies in Asian Americans with chronic hepatitis C and advanced liver disease.Individualization of chronic hepatitis C treatment according to the host characteristics.Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6.Fixed-dose combination of sofosbuvir and ledipasvir for the treatment of chronic hepatitis C genotype 1.Efficacy and safety of 3-week response-guided triple direct-acting antiviral therapy for chronic hepatitis C infection: a phase 2, open-label, proof-of-concept study.Healthcare Costs for Chronic Hepatitis C in South Korea from 2009 to 2013: An Analysis of the National Health Insurance Claims' Data.HCV Prevalence in Asian Americans in California.Disparities in liver cancer occurrence in the United States by race/ethnicity and state.Hepatitis C Genotype Prevalence in Monastir Region, Tunisia: Correlation between 5' Untranslated Region (5'UTR), Non-structural 5B (NS5B), and Core Sequences in HCV Subtyping.Toward a simple risk assessment screening tool for HCV infection in Egypt.A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013): do they differ in Egypt?Urgency to treat patients with chronic hepatitis C in Asia.Population Pharmacokinetics of Paritaprevir, Ombitasvir, and Ritonavir in Japanese Patients with Hepatitis C Virus Genotype 1b Infection.Cost-effectiveness of strategy-based approach to treatment of genotype 1 chronic hepatitis C.Ethnic disparities in progression to advanced liver disease and overall survival in patients with chronic hepatitis C: impact of a sustained virological response.Adverse events associated with ribavirin in sofosbuvir-based therapies for patients with chronic hepatitis C: A community practice experience.Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotypes 1-4 and 6 in Myanmar: Real-world experience.HCV Genotype 6 Increased the Risk for Hepatocellular Carcinoma Among Asian Patients With Liver Cirrhosis.Hepatitis B reactivation in patients with chronic hepatitis C undergoing anti-viral therapy with an interferon-free regimen.
P2860
Q22305417-85BBF7E7-FBEB-4028-BBCA-16662BA2B378Q26765752-19D5F20F-AE1E-4141-9EDD-33FE5A3796E0Q27024231-BD2BF255-B23B-4668-902B-9BE3FE932625Q30434752-2DABCCF8-D17C-4BB3-B475-8FA23EAD7DD2Q33559298-8814D33E-6434-4082-83B8-866FEDE79B98Q33626887-DD6FDA91-BD43-45C8-8F12-131D290FD84DQ33807745-DD4CCC23-FD48-44B6-AF99-F569E17E3E0AQ34036824-AC364C12-BC60-4AEB-8489-D5B6E8D9D62DQ35030432-61CA5BC4-2667-4C74-87B7-32B51C06A858Q35093074-88BFAC08-8026-45F2-9128-187989223E91Q35095416-C8CA2C42-D66A-4E86-8EF9-56F23F6681A7Q35153869-A1668610-2B91-4D2F-9AEE-9D8ED17F9E8AQ35602958-1EABBE32-9C7A-47F2-9CF7-76BDDD8BE20BQ35824222-518E7D8C-E931-4751-97F6-3B1C02558484Q35942041-4E9666D7-FE6D-43D3-9F5D-05A9B2492835Q36009124-056467ED-5BF5-4AA4-87F8-8045BB148F1BQ36073408-FCC7798B-7BB8-4634-AFEA-EC8FCB4C6EEFQ36255956-223EE562-DF51-4EF2-8BC0-2361D2F7A610Q36988702-66E0D28E-0B40-47A0-B500-275546F69D53Q37379283-95FD37F6-E95A-49DC-ADB8-2663EB9D58E1Q37454038-4117FDC7-3B55-4C09-B880-3CC4AE9607BCQ37646759-151E0826-5134-4225-A854-CAA5BBF9A859Q37654502-9A2ED1CC-0FE6-40F0-932A-80648BC7B26AQ38164114-C24B7CD9-9ABA-46E6-BC7D-DFE41E01BEF5Q38353529-6E6A81DE-B3BE-4E4E-977F-2E83871E0B58Q38375284-CFE96A77-B6F5-4454-9112-1236FFCAF994Q38629751-A4F60AD4-3C67-4153-83DC-4E106B397F97Q38707521-9F30CD9C-EC07-4F08-A0D3-ABECE5A578AEQ38741005-C654BDE6-193F-49DA-B974-55593744E4D1Q38866070-34169D63-0AE8-4FC6-9F8E-57579E0BCA6BQ38896137-C34E9A1D-1AE0-48F5-B305-97CD8260FE93Q38987518-16793127-61D0-46ED-9463-8CF417014AB7Q39049155-8DD009AE-539F-4D3B-8F02-61BC2D8843B0Q39675766-FBBC60C2-8B86-4FE9-8456-106F294B3E2EQ39910149-0DAA7300-81AC-4256-8C58-05B6F6109D55Q40098372-9C8A622C-067C-4FE5-AA09-A0D2C26098F1Q40125281-1DC27AED-84BC-4910-8D19-A8977E5D7C24Q40213917-57345228-D01C-4BC1-99C1-E1DA36EB8FCFQ40229053-E2798BAE-522E-47E2-AB64-85DAEA3188FEQ40333357-2FBC0D40-D7B1-4027-8877-1731F03719FF
P2860
Systematic review: Asian patients with chronic hepatitis C infection.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Systematic review: Asian patients with chronic hepatitis C infection.
@en
type
label
Systematic review: Asian patients with chronic hepatitis C infection.
@en
prefLabel
Systematic review: Asian patients with chronic hepatitis C infection.
@en
P2860
P356
P1476
Systematic review: Asian patients with chronic hepatitis C infection.
@en
P2093
L H Nguyen
M H Nguyen
P2860
P304
P356
10.1111/APT.12300
P407
P577
2013-04-05T00:00:00Z